Dengue Vaccine Developments
Health ยท Tuesday, 16 June 2026
Concerns arise over Brazil's dengue vaccine suspension affecting India's indigenous vaccine, DengiAll.
Quick highlights
- Brazil suspended its dengue vaccination campaign.
- DengiAll is India's indigenous dengue vaccine.
- Safety and efficacy data are crucial for public health.
Context
Suspension of Brazil's dengue vaccine raises safety concerns.
Key Facts
DengiAll aims to provide protection against all four dengue serotypes.
Significance
Critical for controlling dengue outbreaks in India.
Challenges / Way Forward
Need for robust safety data before rollout.
Exam Angle
Relevant for GS Paper II on health policies.
Remember this
- DengiAll aims for tetravalent immunity.
- Safety concerns must be addressed before rollout.